SFX by Ex Libris Inc.

Title:	Design and performance evaluation of a 20-aperture multipinhole collimator for myocardial perfusion imaging applications
Source:	Physics in Medicine and Biology [0031-9155] Bowen, Jason yr:2013

Basic

Full text

Full text available via EZB-NALIM-00482 IOP Archive NL

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Wen, Patrick Y. "Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group." Journal of clinical oncology 28.11 (2010): 1963-1972.
description	2.	Brandsma, D. "Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas." The lancet oncology 9.5 (2008): 453-61.
description	3.	Yaman, E. "Radiation induced early necrosis in patients with malignant gliomas receiving temozolomide." Clinical neurology and neurosurgery 112.8 (2010): 662-667.
description	4.	Jacobs, D. "Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas." Lancet oncology 12.6 (2011): 583-593.
description	5.	Macdonald, D R R. "Response criteria for phase II studies of supratentorial malignant glioma." Journal of clinical oncology 8.7: 1277-1280.
description	6.	Louis, D. "The 2007 WHO Classification of Tumours of the Central Nervous System." Acta neuropathologica 114.2 (2007): 97-109.
description	7.	Chamberlain, Marc C. "Pseudoprogression in glioblastoma." Journal of clinical oncology 26.26 (2008): 4359-60.
description	8.	Brandsma, D. "Pseudoprogression and pseudoresponse in the treatment of gliomas." Current opinion in neurology ?.6 (2009): 633-638.
description	9.	Brandes, Franceschi, Tosoni, Blatt, Pession, Talli, Alba A A. "MGMT Promoter Methylation Status Can Predict the Incidence and Outcome of Pseudoprogression After Concomitant Radiochemotherapy in Newly Diagnosed Glioblastoma Patients." Journal of clinical oncology 26.13: 2192-7.
description	10.	Franceschi, E. "Disease progression or pseudoprogression after concomitant radiochemotherapy treatment: pitfalls in neurooncology." Neuro-oncology 10.3 (2008): 361-7.
description	11.	Reynolds, Brent A L. "Brain tumour stem cells." Nature reviews. Cancer 6.6 (2006): 425-36.
description	12.	Pfister, S. "Histology and molecular pathology of pediatric brain tumors." Journal of Child Neurology 24.11 (2009): 1375-1386.
description	13.	Phillips, Heidi S S. "Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis." Cancer cell 9.3: 157-173.
description	14.	Stupp, R. "Chemoradiotherapy in malignant glioma: Standard of care and future directions." Journal of clinical oncology 25.26 (2007): 4127-36.
description	15.	Burger, P. "The WHO classification of tumors of the nervous system." Journal of neuropathology and experimental neurology 61.3 (2002): 215-25.
description	16.	Fuller, Gregory N N. "The WHO Classification of Tumours of the Central Nervous System, 4th edition." Archives of pathology & laboratory medicine 132.6 (2008): 906-906.
description	17.	Taylor, June S. "Clinical value of proton magnetic resonance spectroscopy for differentiating recurrent or residual brain tumor from delayed cerebral necrosis." International journal of radiation oncology, biology, physics 36.5 (1996): 1251-1261.
description	18.	Dobelbower, Michael C. "Patterns of failure for glioblastoma multiforme following concurrent radiation and temozolomide." Journal of medical imaging and radiation oncology 55.1 (2011): 77-81.
description	19.	Kang, In C. "Pseudoprogression in patients with malignant gliomas treated with concurrent temozolomide and radiotherapy: potential role of p53." Journal of Neuro - Oncology 102.1 (2010): 157-162.
description	20.	Das, P. "A clinicopathological and molecular analysis of glioblastoma multiforme with long-term survival." Journal of clinical neuroscience 18.1 (2010): 66-70.